首页 | 本学科首页   官方微博 | 高级检索  
检索        


The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis
Authors:Samuel?Shribman  Hasan?Hasan  Shahrzad?Hadavi  Gavin?Giovannoni  Email author" target="_blank">Alastair?J?NoyceEmail author
Institution:1.Department of Neurology,St. George’s Hospital,London,UK;2.Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology,London,UK;3.Department of Neurophysiology,Kings College Hospital,London,UK;4.Blizard Institute,Barts and the London School of Medicine and Dentistry, Queen Mary University of London,London,UK;5.Preventive Neurology Unit, Wolfson Institute of Preventive Medicine,Barts and the London School of Medicine and Dentistry, Queen Mary University of London,London,UK
Abstract:

Background

The BRadykinesia Akinesia INcordination (BRAIN) test is an online keyboard-tapping test previously validated as a sensitive tool for detecting signs of Parkinson’s disease.

Objectives

To determine whether the BRAIN test can measure disability in MS and identify the presence of pyramidal or cerebellar dysfunction.

Methods

Kinesia scores (KS, number of key taps in 30 s), akinesia times (AT, mean dwell time on each key) and incoordination scores (IS, variance of travelling time between keys) were calculated in 39 MS patients. These were correlated against the Expanded Disability Status Scale (EDSS) scores, pyramidal and cerebellar functional system scores and 9-hole peg test scores.

Results

EDSS correlated with KS (r = ? 0.594, p < 0.001), AT (r = 0.464, p = 0.003) and IS (r = 0.423, p = 0.007). 9-HPT scores strongly correlated with KS (r = 0.926, p < 0.001). Pyramidal scores correlated with KS (r = ? 0.517, p < 0.001). Cerebellar scores correlated with KS (r = ? 0.665, p < 0.001), AT (r = 0.567, p < 0.001) and IS (r = 0.546, p = 0.007). Receiver operating characteristic curves demonstrate that KS can distinguish between the presence or absence of pyramidal and cerebellar dysfunction with area under curve 0.840 (p < 0.001) and 0.829 (p < 0.001), respectively.

Conclusions

The BRAIN test can remotely measure disability in MS. Specific scores differ according to the presence and severity of pyramidal or extrapyramidal dysfunction. It demonstrates huge potential in monitoring disease progression in clinical trials.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号